THOMAS KOSTEN to Antineoplastic Agents
This is a "connection" page, showing publications THOMAS KOSTEN has written about Antineoplastic Agents.
Connection Strength
0.130
-
MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694.
Score: 0.130
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.